erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
. is the place to come for breaking news, analysis and for stories that are just too interesting � or too entertaining � to pass up.
.
he has worked with patients under similar circumstances, but is not involved in the first lady’s case.
.
former novartis exec to lead cambridge diabetes startup semma
.
.
.
.